Nutrients Free Full-Text Physicochemical Properties of the Soluble Dietary Fiber from Laminaria japonica and Its Role in the Regulation of Type 2 Diabetes Mice
Laminaria japonica is a large marine brown alga that is annually highly productive. However, due to its underutilization, its potential value is substantially wasted. For example, a lot of Laminaria japonica cellulose remains unused during production of algin. The soluble dietary fiber (SDF) was prepared from the byproducts of Laminaria japonica, and its physicochemical properties were explored. SDF exhibits good water-holding, oil-holding, water-absorbing swelling, glucose and cholesterol absorption capacity, and inhibitory activity of α-amylase and α-glucosidase. In addition, the beneficial effects of SDF in diabetic mice include reduced body weight, lower blood glucose, and relieved insulin resistance. Finally, the intestinal flora and metabolomic products were analyzed from feces using 16S amplicon and LC-MS/MS, respectively. SDF not only significantly changed the composition and structure of intestinal flora and intestinal metabolites, but also significantly increased the abundance of beneficial bacteria Akkermansia, Odoribacter and Bacteroides, decreased the abundance of harmful bacteria Staphylococcus, and increased the content of bioactive substances in intestinal tract, such as harmine, magnolol, arachidonic acid, prostaglandin E2, urimorelin and azelaic acid. Taken together, these findings suggest that dietary intake of SDF alleviates type 2 diabetes mellitus disease, and provides an important theoretical basis for SDF to be used as a functional food.
12 Intervention Trials Show Vitamin C Works for COVID-19
It's is an antioxidant, an anti-viral, and an anti-inflammatory with no reported adverse events in published clinical trials. So why not give it to COVID patients?
Epstein-Barr virus may be leading cause of multiple sclerosis -- ScienceDaily
A new study provides compelling evidence of causality between Epstein-Barr virus and multiple sclerosis. It suggests that most MS cases could be prevented by stopping EBV infection, and that targeting EBV could lead to the discovery of a cure for MS.
A Sea Of Change In COVID Sentiment - A Collapsing Pandemic Narrative
COVID sentiment is changing among top ranks in the U.S. and Europe through the Chinese are continuing to close up cities, shut down vital ports (threatening the world’s supply chain with a huge shock), and believe it or not, are putting their citizens in little boxes. However, talking about a sea of COVID change, the... View Article
Vaccine effectiveness against SARS-CoV-2 infection with the Omicron or Delta variants following a two-dose or booster BNT162b2 or mRNA-1273 vaccination series
In this brief communication we are showing original research results with early estimates from Danish nationwide databases of vaccine effectiveness (VE) against the novel SARS-CoV-2 Omicron variant (B.1.1.529) up to five months after a primary vaccination series with the BNT162b2 or mRNA-1273 vaccines. Our study provides evidence of protection against infection with the Omicron variant after completion of a primary vaccination series with the BNT162b2 or mRNA-1273 vaccines; in particular, we found a VE against the Omicron variant of 55.2% (95% confidence interval (CI): 23.5 to 73.7%) and 36.7% (95% CI: 69.9 to 76.4%) for the BNT162b2 and mRNA-1273 vaccines, respectively, in the first month after primary vaccination. However, the VE is significantly lower than that against Delta infection and declines rapidly over just a few months. The VE is re-established upon revaccination with the BNT162b2 vaccine (54.6%, 95% CI: 30.4 to 70.4%). ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement This study did not receive any funding ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: We used only administrative register data for the study. According to Danish law, ethics approval is exempt for such research, and the Danish Data Protection Agency, which is a dedicated ethics and legal oversight body, thus waives ethical approval for our study of administrative register data, when no individual contact of participants is necessary and only aggregate results are included as findings. The study is therefore fully compliant with all legal and ethical requirements and there are no further processes available regarding such studies. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable. Yes De-identified data are available for access to members of the scientific and medical community for non-commercial use only upon reasonable request to the authors
Effectiveness of COVID-19 vaccines against Omicron or Delta infection medRxiv
Background The incidence of SARS-CoV-2 infection, including among those who have received 2 doses of COVID-19 vaccines, has increased substantially since Omicron was first identified in the province of Ontario, Canada. Methods Applying the test-negative design to linked provincial data, we estimated vaccine effectiveness against infection (irrespective of symptoms or severity) caused by Omicron or Delta between November 22 and December 19, 2021. We included individuals who had received at least 2 COVID-19 vaccine doses (with at least 1 mRNA vaccine dose for the primary series) and used multivariable logistic regression to estimate the effectiveness of two or three doses by time since the latest dose. Results We included 3,442 Omicron-positive cases, 9,201 Delta-positive cases, and 471,545 test-negative controls. After 2 doses of COVID-19 vaccine, vaccine effectiveness against Delta infection declined steadily over time but recovered to 93% (95%CI, 92-94%) ≥7 days after receiving an mRNA vaccine for the third dose. In contrast, receipt of 2 doses of COVID-19 vaccines was not protective against Omicron. Vaccine effectiveness against Omicron was 37% (95%CI, 19-50%) ≥7 days after receiving an mRNA vaccine for the third dose. Conclusions Two doses of COVID-19 vaccines are unlikely to protect against infection by Omicron. A third dose provides some protection in the immediate term, but substantially less than against Delta. Our results may be confounded by behaviours that we were unable to account for in our analyses. Further research is needed to examine protection against severe outcomes. ### Competing Interest Statement K.W. is CEO of CANImmunize and serves on the data safety board for the Medicago COVID-19 vaccine trial. The other authors declare no conflicts of interest. ### Funding Statement This work was supported by the Canadian Immunization Research Network (CIRN) through a grant from the Public Health Agency of Canada and the Canadian Institutes of Health Research (CNF 151944). This project was also supported by funding from the Public Health Agency of Canada, through the Vaccine Surveillance Reference Group and the COVID-19 Immunity Task Force. This study was also supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health (MOH). J.C.K. is supported by Clinician-Scientist Award from the University of Toronto Department of Family and Community Medicine. P.C.A. is supported by a Mid-Career Investigator Award from the Heart and Stroke Foundation. This work was supported by Public Health Ontario. This study was also supported by ICES, which is funded by an annual grant from the Ontario Ministry of Health (MOH) and the Ministry of Long-Term Care (MLTC). This study was supported by the Ontario Health Data Platform (OHDP), a Province of Ontario initiative to support Ontarios ongoing response to COVID-19 and its related impacts. The study sponsors did not participate in the design and conduct of the study; collection, management, analysis and interpretation of the data; preparation, review or approval of the manuscript; or the decision to submit the manuscript for publication. Parts of this material are based on data and/or information compiled and provided by the Canadian Institute for Health Information (CIHI) and by Cancer Care Ontario (CCO). However, the analyses, conclusions, opinions and statements expressed herein are solely those of the authors, and do not reflect those of the funding or data sources; no endorsement by ICES, MOH, MLTC, OHDP, its partners, the Province of Ontario, CIHI or CCO is intended or should be inferred. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Section 45 of PHIPA authorizes ICES to collect personal health information, without consent, for the purpose of analysis or compiling statistical information with respect to the management of, evaluation or monitoring of, the allocation of resources to or planning for all or part of the health system. Projects that use data collected by ICES under section 45 of PHIPA, and use no other data, are exempt from REB review. The use of the data in this project is authorized under section 45 and approved by ICES Privacy and Legal Office. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable. Yes The dataset from this study is held securely in coded form at ICES. While legal data sharing agreements between ICES and data providers (e.g., healthcare organizations and government) prohibit ICES from making the dataset publicly available, access may be granted to those who meet pre-specified criteria for confidential access, available at www.ices.on.ca/DAS (email: das@ices.on.ca).
Loss of Smell Post-Infection Damage to Brain - YouTube
While nutrient deficiencies increase loss of smell and taste, there are other reasons as well.
Infections increase the utilization of zinc and vitamin A heavily which contributes to loss of smell and taste.
However, if you've tried using quality zinc and vitamin A supplements to no avail, perhaps your sense of smell and taste is associated with higher levels of oxidative stress and deficiencies in various antioxidants.
Infections increase the responsiveness by your immune system.
An enhanced immune system increases oxidative stress.
Why?
To kill the pathogen.
Oxidative stress kills bacteria, viruses and other pathogens.
Issue is oxidative stress also hurts us - our own organs - such as our heart and brain.
If our immune system works hard for quite some time, we increase the risk of organ dysfunction.
Increased oxidative stress in our brain may predispose us to loss of smell and taste.
Thus, overcome the infection by supporting your immune system. Then clean up the damage caused by your immune system by using antioxidants.
Antioxidants which are very effective for your brain and other areas:
- PQQ
- Glutathione
- SOD
- Alpha-R-Lipoic Acid
- NAC
Where to buy antioxidants:
https://www.seekinghealth.com/collections/antioxidant-supplements
Research:
https://www.aarp.org/health/brain-health/info-2017/sense-of-smell-loss-dementia-fd.html
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5309413/pdf/OMCL2017-3496043.pdf
https://elifesciences.org/articles/32018
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6625946/pdf/nihms-1013286.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1097/00005537-200211000-00031
https://dta0yqvfnusiq.cloudfront.net/nascent-health/2017/09/PQQ-Short-Version-59bd304fa70bf.pdf
Relative Incidence of Office Visits and Cumulative Rates of Billed Diagnoses Along the Axis of Vaccination - PubMed
We performed a retrospective analysis spanning ten years of pediatric practice focused on patients with variable vaccination born into a practice, presenting a unique opportunity to study the effects of variable vaccination on outcomes. The average total incidence of billed office visits per outcome …
Blood Clotting Symptoms, Causes, and Support Strategies - YouTube
In this video, I will go over what blood viscosity and blood clotting are. I will explain the major symptoms of poor blood viscosity. I will go over the risk factors for blood clotting. You will learn about diagnosis and conventional treatment options for blood clotting. You will understand the major functional root causes of blood clotting. I will share my top natural support strategies for blood clotting.
For more info go here: https://drjockers.com/blood-clotting/
Inflam Defense: https://store.drjockers.com/products/inflam-defense
Use coupon code Jockers10 at checkout to save orders on https://store.drjockers.com/
Shop Discount vitamins & supplements, natural health products, organic foods and more at best prices. Money back guarantee! Shop online or call 1-800-824-4491.
Enhancement of Learning and Memory by Elevating Brain Magnesium-L-threonate
Learning and memory are fundamental brain functions affected by dietary and environmental factors. Here, we show that increasing brain magnesium using…
Melatonin as adjuvant treatment for coronavirus disease 2019 pneumonia patients requiring hospitalization (MAC-19 PRO) a case series Melatonin Research
Melatonin potentials against viral infections including COVID-19 Current evidence and new findings
Viral infections are dangerous diseases for human health worldwide, which lead to significant morbidity and mortality each year. Because of their importance and the lack of effective therapeutic approaches, further attempts should be made to discover ...
COVID-19 Melatonin as a potential adjuvant treatment - PubMed
This article summarizes the likely benefits of melatonin in the attenuation of COVID-19 based on its putative pathogenesis. The recent outbreak of COVID-19 has become a pandemic with tens of thousands of infected patients. Based on clinical features, pathology, the pathogenesis of acute respiratory …
Blurry Vision After Being Sick Why This Happens and How to Support - YouTube
There's a reason why your vision gets worse after being sick.
It has to do with nutrient deficiencies and higher oxidative stress.
Support eye health by supporting nutrition.
Glutathione is a big one as is folate - once again.
Recommended Nutrients:
- Glutathione
- PQQ
- Methylfolate with methylcobalamin
Where to buy:
Active B12 with L-5-MTHF Lozenges
https://www.seekinghealth.com/products/active-b12-with-l-5-mthf-60-lozenges
PQQ Lozenge
https://www.seekinghealth.com/products/pqq-lozenge-30-lozenges
Glutathione
https://www.seekinghealth.com/collections/glutathione-supplements
HomocysteX Plus (to support homocysteine)
https://www.seekinghealth.com/products/homocystex-plus-60-capsules
Papers cited:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048347/pdf/ijgm-4-105.pdf
https://iovs.arvojournals.org/article.aspx?articleid=2124326
https://pubmed.ncbi.nlm.nih.gov/29448287/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5009653/pdf/12886_2016_Article_337.pdf
Hair Loss After Viral Infection Telogen effluvium - YouTube
Experienced hair loss after a viral infection?
There are many types of hair loss. Specifically, I am discussing Telogen effluvium. It is the most common cause of diffuse hair shedding.
There are many reasons why this can happen. I am focusing on one reason.
1. Folate deficiency
Your immune system requires a lot of folate - especially Folinic Acid (NOT folic acid).
Growth of hair requires a lot of folate as well - especially Folinic Acid.
If your immune system uses the majority of your Folinic Acid, your hair is left with very little. The result? Your hair becomes undernourished and falls out.
Folate and B12 work well together so it's best to support with a combination of both.
Consider Hydroxo B12 with Folinic Acid Lozenges by Seeking Health to support healthy hair growth.*
https://www.seekinghealth.com/products/hydroxo-b12-with-folinic-acid-60-lozenges
research:
https://jag.journalagent.com/ijmb/pdfs/IJMB-75047-ORIGINAL_INVESTIGATION-YORULMAZ_ERTUG.pdf
2. Stress / Anxiousness
There is a lot of stress going on right now and this, too, is associated with hair loss.
A woman mentioned to me on Instagram that she has been successfully using Optimal Adrenal to support her stress response. A noted 'side effect' was that her hair also came in thicker and fully. It was an unexpected benefit that she shared with me.
It makes sense.
There's a lot of research looking at stress and hair loss
https://www.mayoclinic.org/healthy-lifestyle/stress-management/expert-answers/stress-and-hair-loss/faq-20057820
If you're struggling with anxiousness or stressful situations, consider Optimal Adrenal by Seeking Health to support a healthy stress response.*
https://www.seekinghealth.com/products/optimal-adrenal-90-capsules
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
Watch Episode 1: Vaccine Truth: Dispelling the Myths
This first episode is packed with the TRUTH about the vaccine. We’ve gathered a group of top vaccine experts who have tried to get the information to you but, instead, have been censored and suppressed.
PLUS, we have a special BRAND NEW BONUS EPISODE tonight, featuring Dr. Peter McCullough and Dr. Bryan Ardis.
You’ll discover the alarming answers to questions about the vaccine that the “experts” don’t want you to know.
What Dr. Peter McCullough, an internist and cardiologist in Dallas, Texas, had to say about the deadly spike protein will leave you speechless.
Even U.S. federal agencies are trying to cover up the research coming out about the harmful vaxx (unsuccessfully, as Dr. McCullough reveals).
He goes into detail about the hundreds and hundreds of cases all around the world of top athletes dropping dead on the playing field. This is extremely alarming to hear.
And the rest of what he covers includes even more disturbing studies, revealing data about vaxxed victim’s autopsies and shocking news you won't hear anywhere else.
Dr. Bryan Ardis dives into numerous disturbing facts that will leave your brain spinning.
For example, why are male teenagers showing 20x the heart problems after the jab than the CDC expected (surely they told the FDA about this, right?)
And you have to hear what he had to say about the shocking statement he found in the American Heart Association’s Circulation Journal regarding what they’ve seen happening to patients’ hearts after receiving the jab…
Turns out it has been a MASSIVE coverup. Who would have guessed that?
Dr. Ardis also discusses the one disease happening after the jab that’s worrying doctors all over the world (once diagnosed, 20% will die in 2 years, 50% will die in 5 years). You need to hear this directly from Dr. Ardis himself, for your own safety.